Author Archive: Jeremy Parkinson
Biotech: Time To Buy Or Sell? Surprising Stock Tips
Biotechnology is one of those sectors that is totally out of grace after it came down sharply in the second half of 2015, as market volatility rose sharply. The first chart shows that the biotech index (represented by the IBB ETF) lost 40% of its value in just 7 months. Talking about a sharp correction! That could […]
Aeglea Biotherapeutics IPO: Wait For Larger April Deals
Aeglea Biotherapeutics Inc. (AGLE) expects to raise $51.4 million in its upcoming IPO. Based in Austin, Texas, Aeglea Biotherapeutics is a biotechnology company developing enzyme-based therapeutics to treat disorders of metabolism and cancer. AGLE will offer 3.5 million shares at an expected price range of $16 to $18. CRVS filed for the IPO on June 16, 2015. […]
Triffin’s Paradox Revisited: Crunch-Time For The U.S. Dollar And The Global Economy
While all eyes on fixated on global stock markets as the measure of “prosperity” and “growth” (or is it hubris?), the larger force at work beneath the dovish cooing of central bankers is foreign exchange: the relative value of nations’ currencies, which are influenced (like everything else) by supply and demand, which is in turn influenced […]
USDJPY: Pressure Builds Up On Key Support Zone
USDJPY: The pair extended its weakness on Monday leaving lower towards its key support located at the 111.66 level. On the downside, support comes in at the 111.00 level where a break if seen will aim at the 110.50 level. A cut through here will turn focus to the 110.00 level and possibly lower towards […]
Binary Options Assets In Focus – April 5, 2016
The session on Tuesday features of the ISM Non-manufacturing PMI numbers coming out of America, and the Australian central bank releasing its monetary policy statement an interest-rate decision. With this being said, it is not likely to be a major shift in momentum as far as the markets are concerned during the day, but those […]
Groupon Announces $250M Atairos Investment, Potential Partnership With Comcast
Shares of Groupon (GRPN) rallied in morning trading after the company announced a $250M investment from Atairos, the company founded by former Comcast (CMCSA, CMCSK) vice chairman and chief financial officer Michael Angelakis. As a result of the investment, Groupon said that Comcast will work with it to identify and implement possible partnership opportunities and […]
Healthcare Stocks Lead On A Lackluster Day
Healthcare Sector Leads the Market Lagging healthcare and biotech stocks found buyers today. The healthcare SPDR ETF (XLV) was up 1.05% to $69.38 as investors were probably seeking dividends and safety with fears about pricing tempered. The XLV is still down 3.68% YTD. Biotechs came out of the box strong but sold off as the […]
The Fed: Their Dangerous Obsession
Albert discusses his recent interview with James Rickards and takes apart an Financial Times article critical of gold investors. Video Length: 00:18:25
S&P 500 At Important Juncture
Back in November and December of 2014, we released a 7 part series highlighting the weight of evidence piling up against U.S. stocks. In summary, our research showed a market top was upon us. If you weren’t with us back then, you can catch up and dig into our methods using the links below. This […]
E Are Free Trade And Shareholder Wealth Maximization Tarnished Ideas?
American voters are expressing a lack of confidence in free trade and question whether the purpose of a corporation is to maximize shareholder wealth. These two ideas have guided U.S. economic policies for decades. Why are they tarnished in the minds of voters across the political spectrum? Three developments help explain this question: the end […]
